性结肠炎相关的结肠直肠癌和零星结肠直肠癌之间的预后和复发模式的差异:匹配对分析
Kei Kobayashi1,2, Kenichiro Toritani1, Hideaki Kimura3
1Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Annals of surgical oncology
|September 7, 2024
概括
性结肠炎相关的结直肠癌 (UC-CRC) 患者的总体生存率与零星性结直肠癌 (S-CRC) 患者相似. 然而,第三阶段UC-CRC的存活率较低,复发模式不同于S-CRC.
科学领域:
- 胃肠病学 胃肠病学
- 手术瘤学手术瘤学
- 在瘤学瘤学.
背景情况:
- 在性结肠炎相关的结直肠癌 (UC-CRC) 和零星结直肠癌 (S-CRC) 之间存在临床病理学上的差异.
- UC-CRC和S-CRC之间的预测差异仍然存在争议和不清楚.
- 这项研究旨在评估UC-CRC和S-CRC患者之间的临床病理和预后差异.
研究的目的:
- 为了比较UC-CRC和S-CRC之间的临床病理特征和预后.
- 确定任何观察到的预后差异的潜在原因.
主要方法:
- 临床病理学数据和预后的匹配对分析.
- 包括在2000-2021年期间接受结直肠切除的患者.
- 匹配标准包括年龄,性别,手术日期,瘤位置和UICC阶段.
主要成果:
- 共有288名患者 (48名UC-CRC,240名S-CRC) 进行了匹配.
- UC-CRC患者进行了更具侵入性的手术和更长的手术时间,但手术后并发症和死亡率相似.
- 整体5年生存率相似 (86.5%与88.8%),但3期UC-CRC的5年生存率较差 (51.4%与83.8%).
- 复发模式不同:腹/骨在3期UC-CRC与S-CRC中的肝/肺相比.
结论:
- 与S-CRC患者相比,3期UC-CRC患者的预后较差.
- 在UC-CRC中明显的复发模式表明了潜在的生物学差异.
- 对这些差异进行进一步的研究是有必要的,以改善UC-CRC患者的治疗结果.
更多相关视频
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
159
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
159
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Inflammatory Bowel Disease II: Crohn's Disease
205
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
205
Inflammatory Bowel Disease V: Surgical Management
133
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
133
Comparing the Survival Analysis of Two or More Groups
162
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
162


